Trial · NCT02662569
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 23
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percent Change From Baseline in LDL-C at the Mean of Weeks 10 and 12 | Baseline and weeks 10 and 12 | |
| Primary | Percent Change From Baseline in LDL-C at Week 12 | Baseline and week 12 | |
| Secondary | Change From Baseline in LDL-C at the Mean of Weeks 10 and 12 | Baseline and weeks 10 and 12 | |
| Secondary | Change From Baseline in LDL-C at Week 12 | Baseline and week 12 | |
| Secondary | Percent Change From Baseline in Non-HDL-C at the Mean of Weeks 10 and 12 | Baseline and weeks 10 and 12 | |
| Secondary | Percent Change From Baseline in Non-HDL-C at Week 12 | Baseline and week 12 | |
| Secondary | Percent Change From Baseline in Apolipoprotein B100 at the Mean of Weeks 10 and 12 | Baseline and weeks 10 and 12 | |
| Secondary | Percent Change From Baseline in Apolipoprotein B100 at Week 12 | Baseline and week 12 | |
| Secondary | Percent Change From Baseline in Total Cholesterol at the Mean of Weeks 10 and 12 | Baseline and weeks 10 and 12 | |
| Secondary | Percent Change From Baseline in Total Cholesterol at Week 12 | Baseline and week 12 | |
| Secondary | Percent Change From Baseline in Total Cholesterol/HDL-C Ratio at the Mean of Weeks 10 and 12 | Baseline and weeks 10 and 12 | |
| Secondary | Percent Change From Baseline in Total Cholesterol/HDL-C Ratio at Week 12 | Baseline and week 12 | |
| Secondary | Percent Change From Baseline in Apolipoprotein B100/Apolipoprotein A1 Ratio at the Mean of Weeks 10 and 12 | Baseline and weeks 10 and 12 | |
| Secondary | Percent Change From Baseline in Apolipoprotein B100/Apolipoprotein A1 Ratio at Week 12 | Baseline and week 12 | |
| Secondary | Percentage of Participants With Mean LDL-C at Weeks 10 and 12 of Less Than 70 mg/dL (1.8 mmol/L) | Weeks 10 and 12 | |
| Secondary | Percentage of Participants With LDL-C Less Than 70 mg/dL (1.8 mmol/L) at Week 12 | Week 12 | |
| Secondary | Percent Change From Baseline in Lipoprotein(a) at the Mean of Weeks 10 and 12 | Baseline and weeks 10 and 12 | |
| Secondary | Percent Change From Baseline in Lipoprotein(a) at Week 12 | Baseline and week 12 | |
| Secondary | Percent Change From Baseline in Triglycerides at the Mean of Weeks 10 and 12 | Baseline and weeks 10 and 12 | |
| Secondary | Percent Change From Baseline in Triglycerides at Week 12 | Baseline and week 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02662569/registered